New particle treatment tested for Women's fibroid relief
NCT ID NCT06153667
Summary
This study is observing the safety and effectiveness of Bearing nsPVA particles when used in a procedure called uterine artery embolization to treat symptomatic uterine fibroids. It will follow 100 adult women for 6 months after their procedure. The main goals are to check for serious device-related problems within 30 days and to see if symptoms improve by at least 50% after 6 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Alfred Health
RECRUITINGSydney, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Astra Vascular/Astra Vein Treatment Center
RECRUITINGBrooklyn, New York, 11234, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Royal Gwent Hospital (Aneurin Bevan UHB)
RECRUITINGNewport, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The Wesley Hospital
RECRUITINGBrisbane, Australia
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.